PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: CANCER OF THE BREAST.
D000740:Anemia; D000750:Anemia, Myelophthisic; D000970:Antineoplastic Agents; D001943:Breast Neoplasms; D004358:Drug Therapy; D004890:Erythema; D004967:Estrogens / Q000627:therapeutic use*; D006801:Humans; D006918:Hydroxyurea; D009369:Neoplasms / Q000532:radiotherapy*; D010859:Pigmentation Disorders; D011832:Radiation Injuries; D014116:Toxicology; D014508:Urea
D000970:Antineoplastic Agents; D004967:Estrogens; D014508:Urea; D006918:Hydroxyurea
ANEMIA, MYELOPHTHISIC; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DRUG THERAPY; ERYTHEMA; ESTROGENS, THERAPEUTIC; NEOPLASM RADIOTHERAPY; PIGMENTATION DISORDERS; RADIATION INJURY; TOXICOLOGIC REPORT; UREA